The renin-angiotensin pathway in posttraumatic stress disorder: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are associated with fewer traumatic stress symptoms

Journal of Clinical Psychiatry

Volumn 73, Issue 6, 2012, Pages 849-855

  Khoury, Nayla M ^a   Marvar, Paul J ^a   Gillespie, Charles F ^a   Wingo, Aliza ^a   Schwartz, Ann ^a   Bradley, Bekh ^a   Kramer, Michael ^a   Ressler, Kerry J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ADULT DISEASE; AGE; ANXIETY DISORDER; ARTICLE; CHILDHOOD INJURY; CLINICIAN ADMINISTERED POSTTRAUMATIC STRESS DISORDER SCALE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; DSM-IV; FEMALE; GENDER; HUMAN; HYPERAROUSAL; INCOME; INTRUSIVE THOUGHT; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POSTTRAUMATIC STRESS DISORDER; POSTTRAUMATIC STRESS DISORDER SYMPTOM SCALE; PRIORITY JOURNAL; PROPHYLAXIS; PSYCHOLOGICAL RATING SCALE; PSYCHOTRAUMA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SOCIAL AVOIDANCE BEHAVIOR; THOUGHT DISORDER; UNEMPLOYMENT;

EID: 84863539019     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.11m07316     Document Type: Article

References (38)

1. Gillespie CF, Bradley B, Mercer K, et al. Trauma exposure and stress-related disorders in inner city primary care patients. Gen Hosp Psychiatry. 2009;31(6):505-514. doi:10.1016/j.genhospsych.209.05.03 PubMed
2. Kessler RC, Sonnega A, Bromet E, et al. Posttraumatic stress disorder in the National Comorbidity survey. Arch Gen Psychiatry. 1995;52(12):1048-1060. PubMed
3. McFarlane AC. The long-term costs of traumatic stress: intertwined physical and psychological consequences. World Psychiatry. 2010;9(1):3-10. PubMed
4. Heppner PS, Crawford EF, Haji UA, et al. The association of posttraumatic stress disorder and metabolic syndrome: a study of increased health risk in veterans. BMC Med. 2009;7:1. PubMed
5. Lehman BJ, Taylor SE, Kiefe CI, et al. Relationship of early life stress and psychological functioning to blood pressure in the CARDIA study. Health Psychol. 2009;28(3):338-346. doi:10.1037/a013785 PubMed
6. Kibler JL. Posttraumatic stress and cardiovascular disease risk. J Trauma Dissociation. 2009;10(2):135-150. doi:10.1080/152973080262457 PubMed
7. Tucker P, Jeon-Slaughter H, Pfefferbaum B, et al. Emotional and biological stress measures in Katrina survivors relocated to Oklahoma. Am J Disaster Med. 2010;5(2):113-125. PubMed doi:10.505/ajdm.2010.013
8. Ulmer CS, Calhoun PS, Edinger JD, et al. Sleep disturbance and baroreceptor sensitivity in women with posttraumatic stress disorder. J Trauma Stress. 2009;22(6):643-647. PubMed
9. Buckley TC, Kaloupek DG. A meta-analytic examination of basal cardiovascular activity in posttraumatic stress disorder. Psychosom Med. 2001;63(4):585-594. (Pubitemid 32695139)
10. Pole N. The psychophysiology of posttraumatic stress disorder: a meta-analysis. Psychol Bull. 2007;133(5):725-746. doi:10.1037/03-2909.13.5.725 PubMed
11. Barra S, Vitagliano A, Cuomo V, et al. Vascular and metabolic effects of angiotensin II receptor blockers. Expert Opin Pharmacother. 2009;10(2):173-189. doi:10.1517/14656560802653180 PubMed
12. Anderson C. More indirect evidence of potential neuroprotective benefits of angiotensin receptor blockers. J Hypertens. 2010;28(3):429. doi:10.1097/HJH.0b013e32837135 PubMed
13. Grobe JL, Grobe CL, Beltz TG, et al. The brain renin-angiotensin system controls divergent efferent mechanisms to regulate fluid and energy balance. Cell Metab. 2010;12(5):431-442. doi:10.1016/j.cmet.2010.09.01 PubMed
14. Yu Y, Wang Y, Zhou LN, et al. ARB treatment prevents the decrease in endothelial progenitor cells and the loss of renal microvasculature in remnant kidney. Am J Nephrol. 2011;33(6):550-557. doi:10.159/0328632 PubMed
15. Papademetriou V, Farsang C, Elmfeldt D, et al; Study on Cognition and Prognosis in the Elderly study group. Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE). J Am Coll Cardiol. 2004;44(6):1175-1180. PubMed (Pubitemid 39208870)
16. Zanchetti A, Elmfeldt D. Findings and implications of the Study on Cognition and Prognosis in the Elderly (SCOPE) - a review. Blood Press. 2006;15(2):71-79. doi:10.1080/080370506071583 PubMed (Pubitemid 43878912)
17. Matsumoto S, Shimodozono M, Miyata R, et al. The angiotensin II type 1 receptor antagonist olmesartan preserves cerebral blood flow and cerebrovascular reserve capacity, and accelerates rehabilitative outcomes in hypertensive patients with a history of stroke. Int J Neurosci. 2010;120(5):372-380. doi:10.3109/020745090389362 PubMed
18. Dandona P, Kumar V, Aljada A, et al. Angiotensin II receptor blocker valsartan suppresses reactive oxygen species generation in leukocytes, nuclear factor-kappa B, in mononuclear cells of normal subjects: evidence of an antiinflammatory action. J Clin Endocrinol Metab. 2003;88(9):4496-4501. doi:10.1210/jc.202-021836 PubMed (Pubitemid 37153762)
19. Saavedra JM, Sanchez-Lemus E, Benicky J. Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: therapeutic implications. Psychoneuroendocrinology. 2011;36(1):1-18. PubMed
20. Benicky J, Sánchez-Lemus E, Honda M, et al. Angiotensin II AT(1) receptor blockade ameliorates brain inflammation. Neuropsychopharmacology. 2011;36(4):857-870. doi:10.1038/np.2010.25 PubMed
21. Chen D, Grecca LL, Head GA, et al. Blood pressure reactivity to emotional stress is reduced in AT1A- receptor knockout mice on normal, but not high salt intake. Hypertens Res. 2009.
22. Li NC, Lee A, Whitmer RA, et al. Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ. 2010;340:b5465. doi:10.136/bmj.b5465 PubMed
23. Saxby BK, Harrington F, Wesnes KA, et al. Candesartan and cognitive decline in older patients with hypertension: a substudy of the SCOPE trial. Neurology. 2008;70(19, pt 2):1858-1866. PubMed (Pubitemid 351653953)
24. Weber MA. Angiotensin-II receptor blockers for hypertension and heart failure: quality of life and outcomes. Manag Care Interface. 2005;18(2):47-54. PubMed (Pubitemid 40740546)
25. Baghai TC, Binder EB, Schule C, et al. Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism. Mol Psychiatry. 2006;11(11):1003-1015. doi:10.1038/sj.mp.40184 PubMed (Pubitemid 44631643)
26. Schwartz AC, Bradley R, Penza KM, et al. Pain medication use among patients with posttraumatic stress disorder. Psychosomatics. 2006;47(2):136-142. doi:10.176/api.psy.47.2.136 PubMed (Pubitemid 43346961)
27. Schwartz AC, Bradley R, Ressler KJ, et al. Treating posttraumatic stress disorder in urban African American mental health patients. J Am Psychoanal Assoc. 2004;52(2):464-465. PubMed
28. Pike JL, Smith TL, Hauger RL, et al. Chronic life stress alters sympathetic, neuroendocrine, and immune responsivity to an acute psychological stressor in humans. Psychosom Med. 1997;59(4):447-457. PubMed (Pubitemid 27315247)
29. Schwartz AC, Bradley RL, Sexton M, et al. Posttraumatic stress disorder among African Americans in an inner city mental health clinic. Psychiatr Serv. 2005;56(2):212-215. doi:10.176/api.ps.56.2.212 PubMed (Pubitemid 40216781)
30. Foa EB, Tolin DF. Comparison of the PTSD Symptom Scale-Interview Version and the Clinician-Administered PTSD scale. J Trauma Stress. 2000;13(2):181-191. doi:10.1023/A:10781909213 PubMed (Pubitemid 30333790)
31. Coffey SF, Dansky BS, Falsetti SA, et al. Screening for PTSD in a substance abuse sample: psychometric properties of a modified version of the PTSD Symptom Scale Self-Report. Posttraumatic stress disorder. J Trauma Stress. 1998;11(2):393-399. doi:10.1023/A:102467507565 PubMed (Pubitemid 28169727)
32. Weathers FW, Keane TM, Davidson JRT. Clinician-administered PTSD scale: a review of the first ten years of research. Depress Anxiety. 2001;13(3):132-156. doi:10.102/da.1029 PubMed (Pubitemid 32467173)
33. Blake DD, Weathers FW, Nagy LM, et al. A clinician rating scale for assessing current lifetime PTSD: the CAPS-1. Behav Ther. 1990;13:187-188.
34. Bernstein DP, Fink L, Handelsman L, et al. Initial reliability and validity of a new retrospective measure of child abuse and neglect. Am J Psychiatry. 1994;151(8):1132-1136. PubMed (Pubitemid 24240954)
35. Bernstein DP, Ahluvalia T, Pogge D, et al. Validity of the Childhood Trauma Questionnaire in an adolescent psychiatric population. J Am Acad Child Adolesc Psychiatry. 1997;36(3):340-348. doi:10.1097/04583-197030-012 PubMed (Pubitemid 27097927)
36. Strawn JR, Geracioti TD Jr. Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder. Depress Anxiety. 2008;25(3):260-271. doi:10.102/da.20292 PubMed (Pubitemid 351499905)
37. Reid IA. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol. 1992;262(6, pt 1):E763-E778. PubMed
38. Fletcher S, Creamer M, Forbes D. Preventing post traumatic stress disorder: are drugs the answer? Aust N Z J Psychiatry. 2010;44(12):1064-1071. doi:10.3109/048674.2010.509858 PubMed